Rocket One Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Rocket One Inc. (RKTO) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$63.26 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-14
- Rocket One Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$48.86K.
- Rocket One Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$14.41K.
- Rocket One Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $447.91K, a 1797.53% increase year-over-year.
- Rocket One Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $655.78K, a 410.45% increase year-over-year.
- Rocket One Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $644.17K, a 320.99% increase from fiscal 2024.
- Rocket One Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $153.01K.
- Rocket One Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$700.75K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$48.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$63.26K 10-Q · filed 2026-08-14 | $384.65K derived: sum of 3 quarters · filed 2026-08-14 | $1.04M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$14.41K 10-Q · filed 2026-05-15 | $433.51K derived: sum of 2 quarters · filed 2026-05-15 | $1.09M derived: sum of 3 quarters · filed 2026-05-15 | $646.15K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $447.91K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.10M derived: sum of 2 quarters · filed 2026-03-27 | $660.56K derived: sum of 3 quarters · filed 2026-08-14 | $644.17K 10-K · filed 2026-03-27 |
| 2025-09-30 | $655.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $212.65K derived: sum of 2 quarters · filed 2026-08-14 | $196.25K 10-Q · filed 2025-11-12 | $219.86K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$443.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$459.53K 10-Q · filed 2026-08-14 | -$435.92K derived: sum of 3 quarters · filed 2026-08-14 | -$307.45K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$16.39K 10-Q · filed 2026-05-15 | $7.21K derived: sum of 2 quarters · filed 2026-05-15 | $135.68K derived: sum of 3 quarters · filed 2026-05-15 | $175.92K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $23.61K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $152.07K derived: sum of 2 quarters · filed 2026-03-27 | $192.32K derived: sum of 3 quarters · filed 2026-03-27 | $153.01K 10-K · filed 2026-03-27 |
| 2024-09-30 | $128.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $168.71K derived: sum of 2 quarters · filed 2025-11-12 | $129.41K 10-Q · filed 2025-11-12 | -$1.11M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $40.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $938.00 10-Q · filed 2025-08-12 | -$1.24M derived: sum of 3 quarters · filed 2025-08-12 | -$1.03M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$39.30K 10-Q · filed 2025-05-12 | -$1.28M derived: sum of 2 quarters · filed 2025-05-12 | -$1.07M derived: sum of 3 quarters · filed 2025-05-12 | |
| 2023-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$1.03M derived: sum of 2 quarters · filed 2025-03-28 | -$700.75K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $207.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $538.12K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $330.93K 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |